Costs of radium-223 and the pharmacy preparation
            <sup>177</sup>
            Lu-PSMA-I&amp;T for metastatic castration-resistant prostate cancer in Dutch hospitals

Quist, S W; Paulissen, J H J; Wyndaele, Dirk; Nagarajah, James; Freriks, Roel

doi:10.1080/13696998.2023.2183618

Cited by 3 publications

(1 citation statement)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, reports of economic evaluations are essential. Quist et al compared treatment costs of in-house produced [ 177 Lu]Lu-PSMA-I&T and compared it to costs of radium-223 therapy (Quist et al 2023 ). Based on an economic evaluation model, it was concluded that treatment costs per patient with the in-house preparation of [ 177 Lu]Lu-PSMA-I&T (VISION trial scheme) were higher than radium-223 therapy (€47.456 vs € 30.905, respectively).…”

Section: Costs Of In-house Preparation and Treatment With [ ...mentioning

confidence: 99%

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

DaSilva,

Decristoforo,

Mach

et al. 2023

EJNMMI radiopharm. chem.

View full text Add to dashboard Cite

Background The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Main body This selection of highlights provides commentary on 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals. Conclusion Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.

show abstract

Section: Costs Of In-house Preparation and Treatment With [ ...mentioning

confidence: 99%

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

DaSilva,

Decristoforo,

Mach

et al. 2023

EJNMMI radiopharm. chem.

View full text Add to dashboard Cite

show abstract

Dual therapy in metastatic castration-resistant prostate cancer

Huang,

Leng

2024

The Lancet Oncology

View full text Add to dashboard Cite

Phytoremediation of radium contaminated soils: recent advances and prospects

Wang,

Chen

2024

Radiochimica Acta

View full text Add to dashboard Cite

Radioactive radium (Ra) mainly comes from the mining and milling of uranium and other metal or non-metal mines, phosphate production and fertilizer use, production of oil and gas, coal combustion, wastewater treatment, and various wastes from the above activities, which is ubiquitous in the environment. Phytoremediation is a green and cheap remediation technology for metal/radionuclide-contaminated sites. Radium is often of particular interest and there are many literatures on parameters of Ra concentration in plants and transfer factors from soil to plant from a radiological impact assessment point of view. However, review articles on phytoremediation of Ra-polluted soil are relatively few. This review focused on radium-polluted soil phytoremediation, involving two main strategies of phytoextraction and phytostabilization, which covered the potential (hyper)accumulators for Ra, characteristics of Ra uptake from soil by plants, influencing factors, and phytostabilization application. In future research works, more attention should be paid to the deep insights and mechanism researches of Ra uptake/immobilization by plants. This review will deepen the understanding of the relationship of radium-soil-plants, and to enhance the potential application of phytoremediation as an alternative treatment technology for remediation of Ra-polluted soil site.

show abstract

Costs of radium-223 and the pharmacy preparation ¹⁷⁷ Lu-PSMA-I&T for metastatic castration-resistant prostate cancer in Dutch hospitals

Cited by 3 publications

References 14 publications

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Dual therapy in metastatic castration-resistant prostate cancer

Phytoremediation of radium contaminated soils: recent advances and prospects

Contact Info

Product

Resources

About

Costs of radium-223 and the pharmacy preparation 177 Lu-PSMA-I&T for metastatic castration-resistant prostate cancer in Dutch hospitals

Cited by 3 publications

References 14 publications

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Dual therapy in metastatic castration-resistant prostate cancer

Phytoremediation of radium contaminated soils: recent advances and prospects

Contact Info

Product

Resources

About

Costs of radium-223 and the pharmacy preparation ¹⁷⁷ Lu-PSMA-I&T for metastatic castration-resistant prostate cancer in Dutch hospitals